cidofovir anhydrous has been researched along with Pneumonia, Viral in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 5 (27.78) | 29.6817 |
2010's | 5 (27.78) | 24.3611 |
2020's | 7 (38.89) | 2.80 |
Authors | Studies |
---|---|
Al Rumaih, Z; Chaudhri, G; Karupiah, G; Kc, R; Kels, MJT; Ng, E; Pandey, P | 1 |
Choi, JY; Huh, K; Jhun, BW; Ko, JH; Lim, JU; Oh, HS; Peck, KR; Yoo, H | 1 |
Alcamo, AM; Alessi, LJ; Chong, HJ; Green, M; Simon, DW; Williams, JV; Wolf, MS | 1 |
Bose, N; Chowdhury, K; Pal, P; Poddar, A; Saha, A | 1 |
Anderson, TK; Chien, M; Jockusch, S; Ju, J; Kirchdoerfer, RN; Kumar, S; Li, X; Russo, JJ; Tao, C | 1 |
Baravalle-Einaudi, M; Bosdure, E; Dubus, JC; La Fay, C; Mazenq, J; Stremler-Le Bel, N | 1 |
Choe, J; Chung, CR; Jeon, K; Moon, SM; Na, SJ; Suh, GY | 1 |
Chou, S; Ercolani, RJ; Lefterova, MI; Pinsky, BA; Sahoo, MK; Strasfeld, LM | 1 |
Athas, DM; Bruminhent, J; Flomenberg, P; Hess, BD | 1 |
Eiz-Vesper, B; Heim, A; Maecker-Kolhoff, B; Schultze-Florey, RE; Schwerk, N; Tischer, S | 1 |
Berger, A; Christopeit, M; Hauf, E; Hentrich, M; Heussel, CP; Kalkreuth, J; Klein, M; Kochanek, M; Lehners, N; Mayer, K; Penack, O; Rieger, C; Schalk, E; Silling, G; Vehreschild, M; von Lilienfeld-Toal, M; Weber, T; Wolf, HH | 1 |
Jeong, I; Kim, JH; Kim, S; Kwon, OJ; Kwon, SJ; Lee, M; Na, MJ; Park, HW; Son, JW; Yoon, YS | 1 |
Darr, S; Heim, A; Madisch, I | 1 |
Dishop, MK; Doan, ML; Elidemir, O; Heinle, JS; Kaplan, SL; Mallory, GB; McKenzie, ED; Schecter, MG | 1 |
Bermudez, C; Kormos, R; McCurry, K; McNamara, D; Refaat, M; Shullo, M; Teuteberg, J; Toyoda, Y | 1 |
Bruggeman, CA; de Clercq, E; Havenith, M; Stals, FS; Zeytinoglu, A | 1 |
Distler, A; Ketteler, M; Mertz, A; Offermann, G; Preuschof, L; Schäfer, H; Stöffler-Meilicke, M | 1 |
Bailey, KW; Sidwell, RW; Smee, DF | 1 |
4 review(s) available for cidofovir anhydrous and Pneumonia, Viral
Article | Year |
---|---|
Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Child, Preschool; Cidofovir; Combined Modality Therapy; Consciousness Disorders; Extracorporeal Membrane Oxygenation; Humans; Immunocompetence; Male; Multiple Organ Failure; Nose; Patient Acuity; Pneumonia, Viral; Polymerase Chain Reaction; Radiography, Thoracic; Respiratory Distress Syndrome; Shock | 2020 |
Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Arthritis, Juvenile; Child, Preschool; Cidofovir; Combined Modality Therapy; Cyclosporine; Female; Humans; Macrophage Activation Syndrome; Methylprednisolone; Pneumonia, Viral; Radiography, Thoracic | 2020 |
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Community-Acquired Infections; Cytosine; Germany; Hand Hygiene; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Influenza, Human; Lung; Masks; Medical Oncology; Metapneumovirus; Neoplasms; Neuraminidase; Nucleic Acid Amplification Techniques; Organophosphonates; Oseltamivir; Paramyxoviridae Infections; Patient Isolation; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Tomography, X-Ray Computed; Virus Diseases | 2016 |
Treatment of Adenoviral Acute Respiratory Distress Syndrome Using Cidofovir With Extracorporeal Membrane Oxygenation.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Cytosine; Extracorporeal Membrane Oxygenation; Female; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Pneumonia, Viral; Radiography; Respiratory Distress Syndrome; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
14 other study(ies) available for cidofovir anhydrous and Pneumonia, Viral
Article | Year |
---|---|
Targeting ectromelia virus and TNF/NF-κB or STAT3 signaling for effective treatment of viral pneumonia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cidofovir; Cytokines; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ectromelia virus; Etanercept; Female; Lung; Mice, Inbred C57BL; NF-kappa B; Pneumonia, Viral; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Viral Load | 2022 |
Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Antiviral Agents; Cidofovir; Hospitals, Military; Humans; Male; Pneumonia, Viral; Republic of Korea; Respiratory Insufficiency; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2020 |
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
Topics: Antiviral Agents; Betacoronavirus; Cidofovir; Coronavirus Infections; COVID-19; Dideoxynucleosides; Ganciclovir; Guanine; Nucleotides; Pandemics; Pneumonia, Viral; Prodrugs; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Stavudine; Valganciclovir | 2020 |
Severe adenovirus pneumonia with hemophagocytic syndrome and respiratory failure.
Topics: Adenovirus Infections, Human; Antiviral Agents; Bronchiectasis; Bronchiolitis Obliterans; Chronic Disease; Cidofovir; Combined Modality Therapy; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; Severity of Illness Index | 2020 |
Comparative Study on the Effect of Cidofovir Treatment for Severe Adenovirus Pneumonia.
Topics: Adenoviridae; Adenoviridae Infections; Adult; Cidofovir; Humans; Male; Pneumonia, Viral; Prospective Studies; Respiration, Artificial | 2021 |
Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; High-Throughput Nucleotide Sequencing; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Organophosphonates; Pneumonia, Viral; Time Factors; Viral Proteins; Virus Replication | 2014 |
Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Aged; Antiviral Agents; Cidofovir; Conjunctivitis; Cytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Organophosphonates; Pneumonia, Viral; Postoperative Complications; Transplant Recipients | 2015 |
Monitoring of adenovirus (ADV)-specific T cells in a boy with ADV pneumonia and disseminated disease after lung transplantation.
Topics: Adenoviridae; Adenovirus Infections, Human; Antiviral Agents; Bronchoalveolar Lavage Fluid; Child, Preschool; Cidofovir; Cytosine; Enzyme-Linked Immunospot Assay; Feasibility Studies; Flow Cytometry; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Monitoring, Physiologic; Organophosphonates; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; T-Lymphocytes; Viral Load | 2016 |
Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia.
Topics: Adenoviridae Infections; Adenoviruses, Human; Antiviral Agents; Cidofovir; Cytosine; Humans; Inhibitory Concentration 50; Organophosphonates; Pneumonia, Viral; Ribavirin; United States | 2008 |
Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.
Topics: Adenovirus Infections, Human; Antiviral Agents; Child, Preschool; Cidofovir; Community-Acquired Infections; Cytosine; Humans; Immunocompromised Host; Infant; Lung Transplantation; Organophosphonates; Pneumonia, Viral | 2007 |
Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia.
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Cytosine; Extracorporeal Membrane Oxygenation; Heart Transplantation; Humans; Male; Middle Aged; Organophosphonates; Pneumonia, Viral; Severity of Illness Index; Treatment Outcome | 2008 |
Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine.
Topics: Animals; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Ganciclovir; Immunohistochemistry; Lung; Male; Organophosphonates; Organophosphorus Compounds; Paraffin Embedding; Pneumonia, Viral; Rats; Whole-Body Irradiation | 1993 |
Fatal cytomegalovirus pneumonia after preemptive antiviral therapy in a renal transplant recipient.
Topics: Antigens, Viral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Fatal Outcome; Female; Foscarnet; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pneumonia, Viral; Polymerase Chain Reaction; Postoperative Complications | 2000 |
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox virus; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Nose; Organ Specificity; Organophosphonates; Organophosphorus Compounds; Paranasal Sinuses; Pneumonia, Viral; Spleen; Vaccinia; Vaccinia virus; Viral Load; Viremia | 2001 |